SCHEMBL19081855

SCHEMBL19081855

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc5sc6c(ccc7oc8ccc9ccccc9c8c76)c5c4)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 7/20 0.37
PAX8 Q06710 2/20 0.37
CYP1A1 P04798 2/20 0.37
AHR P35869 2/20 0.37
CYP1A2 P05177 1/20 0.37
FYN P06241 1/20 0.37
MAPK3 P27361 1/20 0.37
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
RAB9A P51151 1/20 0.32
LIMK1 P53667 1/20 0.32
CYP1B1 Q16678 1/20 0.32
F9 P00740 1/20 0.32
MAPK1 P28482 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081858 0.93 ABCG2 (0.38) ABCG2PAX8CYP1A1AHRCYP1A2
SCHEMBL19082034 0.90 ALOX5 (0.37) ABCG2PAX8CYP1A1AHRCYP1A2
SCHEMBL19081856 0.90 ABCG2 (0.36) ABCG2PAX8CYP1A1AHRCYP1A2
SCHEMBL19081903 0.89 ABCG2 (0.38) ABCG2PAX8CYP1A1AHRCYP1A2
SCHEMBL19081870 0.89 ABCG2 (0.38) ABCG2PAX8CYP1A1AHRCYP1A2
SCHEMBL19082049 0.88 ALOX5 (0.33) ABCG2PAX8CYP1A1AHRCYP1A2
SCHEMBL19082176 0.88 CYP1A1 (0.34) CYP1A1KMT2AKDM4EMEN1LIMK1
SCHEMBL19082181 0.88 CYP1A1 (0.35) ABCG2PAX8CYP1A1AHRCYP1A2
SCHEMBL17944339 0.86 CYP1A1 (0.43) CYP1A1CYP1A2KMT2AKDM4EMEN1
SCHEMBL24341392 0.86 LIMK1 (0.32) LIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885PAX8 2336/4885CYP1A1 184/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885PAX8 2336/4885CYP1A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.